RM
Ranga Mahendranath
About Ranga Mahendranath
Data last updated:
Ranga Mahendranath is a Managing Director at Yashikare Lifesciences Private Limited (since 2025). The companies operate in Pharma. Earlier, Ranga Mahendranath was an Additional Director at Slv Life Sciences Private Limited (2021–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 24 Sep 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 10 Apr 2021 | 2017 | ₹2.06 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ranga Mahendranath
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kavitha Cilagani | 11314486 | Yashikare Lifesciences Private Limited | Director |
| Susheela Dodda | 08302185 | Yashikare Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ranga Mahendranath
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ranga Mahendranath
Ranga Mahendranath currently holds 1 directorship: Yashikare Lifesciences Private Limited (Managing Director, since 24 Sep 2025).
Ranga Mahendranath was first appointed on 10 Apr 2021 as Additional Director at Slv Life Sciences Private Limited. The most recent appointment on record is 24 Sep 2025 at Yashikare Lifesciences Private Limited.
Ranga Mahendranath held 1 earlier board appointment: Slv Life Sciences Private Limited (Additional Director, 10 Apr 2021 to 18 Jun 2024).
The current boards of Ranga Mahendranath's companies include Kavitha Cilagani (Yashikare Lifesciences Private Limited), Susheela Dodda (Yashikare Lifesciences Private Limited).